V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |
Exploring the Intersection between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes |
Baylor College of Medicine / Philip Lupo, PhD |
Epidemiology Grants |
2014 |
Texas |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
GSTM4, a novel target for treating Ewing sarcoma.
|
Huntsman Cancer Institute / Wen Luo |
Young Investigator Grants |
2009 |
Utah |
Relationships Between Symptoms and the Hospital Care Environment in Children and Adolescents with Cancer |
Huntsman Cancer Institute / Lauri Linder |
Nurse Researcher Grants |
2010 |
Utah |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |